Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury

J. P. Guo, Manoj Panday, P. M. Consigny, A. M. Lefer

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

We studied the effects of a novel organic nitric oxide (NO) donor, 4- hydroxymethyl-furazan-3-carboxylic acid-2-oxide (CAS-1609), in a rat carotid artery intimal injury model. The NO donor, CAS-1609, or its non-NO-donating control compound, 4-hydroxymethyl-furazan-3-carboxylic acid (C-93-4845), was infused intravenously at 30 μg/day. Seven days after injury, carotid artery rings contracted only 56 ± 6 mg to N(G)-nitro-L-arginine methyl ester in C- 93-4845-treated rats, compared with 120 ± 17 mg in CAS-1609-treated rats (P < 0.02), indicating a preservation of endogenous NO release. Improved responses to the endothelium-dependent dilator, acetylcholine, also occurred in injured arteries treated with CAS-1609. Morphometric analysis of injured carotid arteries given the inactive compound showed marked intimal thickening with an intimal-to-medial ratio (I/M) of 0.76 ± 0.02, compared with a significantly lower I/M of 0.32 ± 0.04 (P < 0.01) in injured carotid arteries given CAS-1609. Additionally, CAS-1609 was found to have a concentration-dependent stimulatory effect on cultured rat aortic endothelial cell proliferation (P < 0.01) but an inhibitory effect on platelet-derived growth factor-BB (10 ng/ml)-stimulated rat aortic smooth muscle cell proliferation (P < 0.01). This is the first study to demonstrate that NO plays a dual role in vascular cell proliferation, stimulating endothelial cells but inhibiting smooth muscle cell proliferation. This dual effect of NO on cell proliferation is associated with an in vivo reduction in neointimal thickening and an acceleration of endothelial recovery determined by both anatomic and functional methods.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume269
Issue number3 38-3
StatePublished - 1995
Externally publishedYes

Fingerprint

Carotid Artery Injuries
Tunica Intima
Nitric Oxide Donors
Blood Vessels
Cell Proliferation
Nitric Oxide
Carboxylic Acids
Carotid Arteries
Oxides
Smooth Muscle Myocytes
Endothelial Cells
NG-Nitroarginine Methyl Ester
Acetylcholine
Endothelium
4-hydroxynethyl-furoxan-3-carboxamide
Arteries

Keywords

  • endothelial cell proliferation
  • endothelium-derived relaxing factor
  • neointimal thickening
  • smooth muscle cell proliferation

ASJC Scopus subject areas

  • Physiology

Cite this

Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. / Guo, J. P.; Panday, Manoj; Consigny, P. M.; Lefer, A. M.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 269, No. 3 38-3, 1995.

Research output: Contribution to journalArticle

@article{f8794784c4c241749a8efb4b55fe2d29,
title = "Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury",
abstract = "We studied the effects of a novel organic nitric oxide (NO) donor, 4- hydroxymethyl-furazan-3-carboxylic acid-2-oxide (CAS-1609), in a rat carotid artery intimal injury model. The NO donor, CAS-1609, or its non-NO-donating control compound, 4-hydroxymethyl-furazan-3-carboxylic acid (C-93-4845), was infused intravenously at 30 μg/day. Seven days after injury, carotid artery rings contracted only 56 ± 6 mg to N(G)-nitro-L-arginine methyl ester in C- 93-4845-treated rats, compared with 120 ± 17 mg in CAS-1609-treated rats (P < 0.02), indicating a preservation of endogenous NO release. Improved responses to the endothelium-dependent dilator, acetylcholine, also occurred in injured arteries treated with CAS-1609. Morphometric analysis of injured carotid arteries given the inactive compound showed marked intimal thickening with an intimal-to-medial ratio (I/M) of 0.76 ± 0.02, compared with a significantly lower I/M of 0.32 ± 0.04 (P < 0.01) in injured carotid arteries given CAS-1609. Additionally, CAS-1609 was found to have a concentration-dependent stimulatory effect on cultured rat aortic endothelial cell proliferation (P < 0.01) but an inhibitory effect on platelet-derived growth factor-BB (10 ng/ml)-stimulated rat aortic smooth muscle cell proliferation (P < 0.01). This is the first study to demonstrate that NO plays a dual role in vascular cell proliferation, stimulating endothelial cells but inhibiting smooth muscle cell proliferation. This dual effect of NO on cell proliferation is associated with an in vivo reduction in neointimal thickening and an acceleration of endothelial recovery determined by both anatomic and functional methods.",
keywords = "endothelial cell proliferation, endothelium-derived relaxing factor, neointimal thickening, smooth muscle cell proliferation",
author = "Guo, {J. P.} and Manoj Panday and Consigny, {P. M.} and Lefer, {A. M.}",
year = "1995",
language = "English (US)",
volume = "269",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "3 38-3",

}

TY - JOUR

T1 - Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury

AU - Guo, J. P.

AU - Panday, Manoj

AU - Consigny, P. M.

AU - Lefer, A. M.

PY - 1995

Y1 - 1995

N2 - We studied the effects of a novel organic nitric oxide (NO) donor, 4- hydroxymethyl-furazan-3-carboxylic acid-2-oxide (CAS-1609), in a rat carotid artery intimal injury model. The NO donor, CAS-1609, or its non-NO-donating control compound, 4-hydroxymethyl-furazan-3-carboxylic acid (C-93-4845), was infused intravenously at 30 μg/day. Seven days after injury, carotid artery rings contracted only 56 ± 6 mg to N(G)-nitro-L-arginine methyl ester in C- 93-4845-treated rats, compared with 120 ± 17 mg in CAS-1609-treated rats (P < 0.02), indicating a preservation of endogenous NO release. Improved responses to the endothelium-dependent dilator, acetylcholine, also occurred in injured arteries treated with CAS-1609. Morphometric analysis of injured carotid arteries given the inactive compound showed marked intimal thickening with an intimal-to-medial ratio (I/M) of 0.76 ± 0.02, compared with a significantly lower I/M of 0.32 ± 0.04 (P < 0.01) in injured carotid arteries given CAS-1609. Additionally, CAS-1609 was found to have a concentration-dependent stimulatory effect on cultured rat aortic endothelial cell proliferation (P < 0.01) but an inhibitory effect on platelet-derived growth factor-BB (10 ng/ml)-stimulated rat aortic smooth muscle cell proliferation (P < 0.01). This is the first study to demonstrate that NO plays a dual role in vascular cell proliferation, stimulating endothelial cells but inhibiting smooth muscle cell proliferation. This dual effect of NO on cell proliferation is associated with an in vivo reduction in neointimal thickening and an acceleration of endothelial recovery determined by both anatomic and functional methods.

AB - We studied the effects of a novel organic nitric oxide (NO) donor, 4- hydroxymethyl-furazan-3-carboxylic acid-2-oxide (CAS-1609), in a rat carotid artery intimal injury model. The NO donor, CAS-1609, or its non-NO-donating control compound, 4-hydroxymethyl-furazan-3-carboxylic acid (C-93-4845), was infused intravenously at 30 μg/day. Seven days after injury, carotid artery rings contracted only 56 ± 6 mg to N(G)-nitro-L-arginine methyl ester in C- 93-4845-treated rats, compared with 120 ± 17 mg in CAS-1609-treated rats (P < 0.02), indicating a preservation of endogenous NO release. Improved responses to the endothelium-dependent dilator, acetylcholine, also occurred in injured arteries treated with CAS-1609. Morphometric analysis of injured carotid arteries given the inactive compound showed marked intimal thickening with an intimal-to-medial ratio (I/M) of 0.76 ± 0.02, compared with a significantly lower I/M of 0.32 ± 0.04 (P < 0.01) in injured carotid arteries given CAS-1609. Additionally, CAS-1609 was found to have a concentration-dependent stimulatory effect on cultured rat aortic endothelial cell proliferation (P < 0.01) but an inhibitory effect on platelet-derived growth factor-BB (10 ng/ml)-stimulated rat aortic smooth muscle cell proliferation (P < 0.01). This is the first study to demonstrate that NO plays a dual role in vascular cell proliferation, stimulating endothelial cells but inhibiting smooth muscle cell proliferation. This dual effect of NO on cell proliferation is associated with an in vivo reduction in neointimal thickening and an acceleration of endothelial recovery determined by both anatomic and functional methods.

KW - endothelial cell proliferation

KW - endothelium-derived relaxing factor

KW - neointimal thickening

KW - smooth muscle cell proliferation

UR - http://www.scopus.com/inward/record.url?scp=0029049330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029049330&partnerID=8YFLogxK

M3 - Article

C2 - 7573510

AN - SCOPUS:0029049330

VL - 269

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 3 38-3

ER -